ABL Diagnostics SA (ABLD) Stock Price & Analysis
ABLD Stock Chart & Stats
- Day’s Range
- EUR 2.44 - EUR 2.50
- 52-Week Range
- EUR 2.10 - EUR 5.00
- Previous Close
- EUR 2.44
- Volume
- N/A
- Average Volume (3M)
- 5,832
- Market Cap
- EUR 39.32M
- Enterprise Value
- EUR 45.63M
- Total Cash (Recent Filing)
- EUR 7.00M
- Total Debt (Recent Filing)
- EUR 180
- Price to Earnings (P/E)
- ―
- Beta
- 0.53
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jul 03, 2026
- Dividend Yield
- 4.44%
ABL Diagnostics SA News
ABL Texcell Diagnostics Moves to Stabilize Shareholder Base as Growth Strategy Accelerates
ABL Diagnostics SA ( ($FR:ABLD) ) just unveiled an update. ABL Texcell Diagnostics’ principal shareholder, Luxembourg-based Advanced Biological Laboratories, has signaled that any future disposals of sizeable share blocks will
All Invest Securities Reaffirms Buy Rating on ABL Texcell Diagnostics as Texcell Integration Boosts Growth Outlook
ABL Diagnostics SA ( ($FR:ABLD) ) has issued an update. ABL Texcell Diagnostics, listed on Euronext Paris, develops molecular diagnostics, healthcare software and integrated solutions for microbiology and infectious disease
ABL Diagnostics Rebrands as ABL Texcell Diagnostics and Keeps Listing on Euronext Paris Main Market
ABL Diagnostics SA ( ($FR:ABLD) ) has provided an announcement. ABL Diagnostics shareholders have approved a change of the company’s corporate name to ABL Texcell Diagnostics, aligning its brand with
ABLD FAQ
What was ABL Diagnostics SA’s price range in the past 12 months?
What is ABL Diagnostics SA’s market cap?
When is ABL Diagnostics SA’s upcoming earnings report date?
How were ABL Diagnostics SA’s earnings last quarter?
Is ABL Diagnostics SA overvalued?
Does ABL Diagnostics SA pay dividends?
What is ABL Diagnostics SA’s EPS estimate?
How many shares outstanding does ABL Diagnostics SA have?
What happened to ABL Diagnostics SA’s price movement after its last earnings report?
Which hedge fund is a major shareholder of ABL Diagnostics SA?
What is the TipRanks Smart Score and how is it calculated?
Company Description
ABL Diagnostics SA
ABL Texcell Diagnostics SA provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and internationally. The company offers genotyping through NGS and sanger sequencing for human immunodeficiency virus, SARS CoV-2, hepatitis-C virus, mycobacterium tuberculosis, and 16S/18S RNA, hepatitis-B Virus (HBV), cytomegalovirus (CMV), herpes simplex virus (HSV), BK virus (BKV), human papillomavirus (HPV), respiratory syncytial virus (RSV), and salmonella; real time PCR assays; ultragene assays for viral detection of SARS CoV-2, MonkeyPox, and Clostridium; microbiological specimen transport and collection kits, which include saliva preservation, wastewater collection, and surface collection kits, as well as inactivation and preservation solution; and instrument and consumables, such as DNA/RNA extraction system, real-time PCR system, liquid handling robot, next generation sequencing (NGS) library preparation kit, and sanger sequencing reaction. It also provides digital solutions comprising analysis software, data hosting, lab automation, Nadis, and SeqHepB. The company sells its products directly, as well as through a network of distributors to academic clinical pathology labs, private reference labs, and researchers. The company was formerly known as ABL Diagnostics Société anonyme and changed its name to ABL Texcell Diagnostics SA in April 2022. The company is headquartered in Woippy, France. ABL Texcell Diagnostics SA operates as a subsidiary of Advanced Biological Laboratories (ABL) S.A.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Jean-Claude Bourcet
- Employees
- 22
- Website
- www.abldiagnostics.com
- Address
- 72c, rue de Thionville, Woippy, IDF, 57140, FR
ABL Diagnostics SA (ABLD) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 13 | 5 | 4 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 10 | 0 | 2 |
